Financial News
Latest News about FDA
Recent news which mentions FDA
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
November 30, 2022
Tickers
REGN
From Benzinga
Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease
November 30, 2022
Tickers
AGLE
From Benzinga
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Tickers
SPPI
From Benzinga
From Benzinga
Canceled AdCom, UniQure's Hemgenix Approval Show Positive Signs For BioMarin's Hemophilia Candidate
November 23, 2022
Tickers
BMRN
From Benzinga
DEA Legalizes Cocaine Derivative As Diagnostic Aid For Parkinson's, Ignoring Cannabis Experts Seeking Same
November 23, 2022
Tickers
DEA
From Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
November 23, 2022
From Benzinga
From Benzinga
From Benzinga
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US
November 22, 2022
Tickers
GSK
From Benzinga
Philips Flags Two Additional Issues With Reworked, Placed Ventilators
November 22, 2022
Tickers
PHG
From Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
November 22, 2022
From Benzinga
Independent Director Jennifer Crandall to Speak about FDA's New FSMA 204 Regulation
November 22, 2022
Tickers
PCYG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
